A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF DEXPRAMIPEXOLE ADMINISTERED ORALLY FOR 52 WEEKS IN PARTICIPANTS WITH SEVERE EOSINOPHILIC ASTHMA _EXHALE-3
- 27472 Schoenherr, Ste 100. Warren, MI. 48088-6854.
- (586) 751-8844